CADTH Is Now Canada’s Drug Agency

In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as:

  • improving the appropriate prescribing and use of medications
  • increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data
  • reducing drug system duplication and lack of coordination.

After working with our health systems partners, including Health Canada and the Canadian Drug Agency Transition Office — and with the full support of our Board of Directors — we are ready to lead the implementation and advance the work of Canada’s Drug Agency.

As of May 1, 2024, we will adopt Canada’s Drug Agency (CDA-AMC) as our new operating name. An official launch will occur later this year. Throughout the summer, we will be updating our communications materials and expanding our operations. For updates on our progress, please subscribe to our monthly newsletter The Dispatch.